Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (181-190 of 307) with videos related to

Pageof 31
Sort By:
European Urology Open Science|January 13, 2022
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) ConsortiumJonathan Olivier, Weiyu Li, Daan Nieboer, et al.
The Journal of Urology|August 5, 2022
Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate CancerSophia M Abusamra, Marissa A Solorzano, Mallory Luke, et al.
European Urology|February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance StudyJames T Kearns, Anna V Faino, Lisa F Newcomb, et al.
Cancer|January 31, 2014
Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancerMichael Hu, Bruce L Jacobs, Jeffrey S Montgomery, et al.
Urology|March 8, 2017
No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge CareTudor Borza, Bruce L Jacobs, Jeffrey S Montgomery, et al.
The Journal of Urology|August 19, 2022
Reply by AuthorsSophia M Abusamra, Marissa A Solorzano, Mallory Luke, et al.
European Urology Open Science|April 17, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing RegistrySteven M Monda, Eugene Oh, Patrick J Lewicki, et al.
Urology|July 25, 2016
Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?Sapan N Ambani, Todd M Morgan, Jeffrey S Montgomery, et al.
Urology|June 25, 2014
Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancerMichael A Kozminski, Ganesh S Palapattu, Rohit Mehra, et al.
Neoplasia (New York, N.Y.)|January 26, 2016
Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate CancerYuanyuan Qiao, Felix Y Feng, Yugang Wang, et al.
Pageof 31

Showing results (181-190 of 307) with videos related to

Sort By:
Pageof 31
European Urology Open Science|January 13, 2022
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) ConsortiumJonathan Olivier, Weiyu Li, Daan Nieboer, et al.
The Journal of Urology|August 5, 2022
Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate CancerSophia M Abusamra, Marissa A Solorzano, Mallory Luke, et al.
European Urology|February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance StudyJames T Kearns, Anna V Faino, Lisa F Newcomb, et al.
Cancer|January 31, 2014
Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancerMichael Hu, Bruce L Jacobs, Jeffrey S Montgomery, et al.
Urology|March 8, 2017
No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge CareTudor Borza, Bruce L Jacobs, Jeffrey S Montgomery, et al.
The Journal of Urology|August 19, 2022
Reply by AuthorsSophia M Abusamra, Marissa A Solorzano, Mallory Luke, et al.
European Urology Open Science|April 17, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing RegistrySteven M Monda, Eugene Oh, Patrick J Lewicki, et al.
Urology|July 25, 2016
Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?Sapan N Ambani, Todd M Morgan, Jeffrey S Montgomery, et al.
Urology|June 25, 2014
Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancerMichael A Kozminski, Ganesh S Palapattu, Rohit Mehra, et al.
Neoplasia (New York, N.Y.)|January 26, 2016
Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate CancerYuanyuan Qiao, Felix Y Feng, Yugang Wang, et al.
Pageof 31